Infectious disease are responsible of high human health burden and cost. Time to diagnosis release and quality of the microrganism detection represent an area of interest for optical fiber based device application. OPTObacteria propose an highly expert consortium in which 4 SME and 4 research peformers from 3 European countries would synergize their efforts to provide a unique Automatic Laboratory Detector (ALD) to deliver a drug resistance report in a 4 or 4-8 hours timeframe. The time is depending on the experiment required, it avoid bacterial grwoth time, typical of the antibiogram typical report and provide an detection up to low ng concentration or even low. With respect to other optical-based device (like SPR, surface plamon resosnance) many limitations are overcome.
Partner
Partner
TYDOCK PHARMA S.r.l(990039813)-COORDINATOR
MOLECULAR DISCOVERY LTD(997468655)-BENEFICIARY
OPTOSMART SRL(991761466)-BENEFICIARY
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA(999840887)-BENEFICIARY
CONSIGLIO NAZIONALE DELLE RICERCHE(999979500)-BENEFICIARY
Centro Regionale Information Communication Technology scrl(986394262)-BENEFICIARY
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS(999991722)-BENEFICIARY
PROYECCION EUROPLAN XXI S.L.(953806142)-BENEFICIARY
FUNDACION PUBLICA ANDALUZA PARA LAGESTION DE LA INVESTIGACION EN SALUD DE SEVILLA(994159888)-BENEFICIARY